Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MannKind (Clinical Program Rights)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A right for the development of pharmaceutical products. The asset comprises of worldwide rights to the immuno-therapeutic cancer, allergy and infectious disease clinical programs of MannKind.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Colby Pharmaceutical
Primary Office
  • 25134 Rye Canyon Loop
  • Suite 300
  • Valencia, CA 91355
  • United States

MannKind (Clinical Program Rights) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore MannKind (Clinical Program Rights)‘s full profile, request access.

Request full access to PitchBook

MannKind (Clinical Program Rights) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore MannKind (Clinical Program Rights)‘s full profile, request access.

Request full access to PitchBook